N. Misawa et al., DIFFERENTIATION OF CAMPYLOBACTER-JEJUNI SEROTYPE O-19 STRAINS FROM NON-O-19 STRAINS BY PCR, Journal of clinical microbiology (Print), 36(12), 1998, pp. 3567-3573
Guillain-Barre syndrome (GBS), a neurologic disease characterized by a
cute paralysis, is frequently preceded by Campylobacter jejuni infecti
on. Serotype O19 strains are overrepresented among GBS-associated C. j
ejuni isolates. We previously showed that all O19 strains tested were
closely related to one another by randomly amplified polymorphic DNA (
RAPD) and restriction fragment length polymorphism analyses. RAPD anal
ysis demonstrated a 1.4-kb band in all O19 strains tested but in no no
n-O19 strains. We cloned this O19-specific band; nucleotide sequence a
nalysis revealed a truncated open reading frame with significant homol
ogy to DNA gyrase subunit B (gyrB) of Helicobacter pylori. PCR using t
he random primer and a primer specific for gyrB showed that in non-O19
strains, the random primer did not recognize the downstream gyrB bind
ing site. The regions flanking each of the random primer binding sites
were amplified by degenerate PCR for further sequencing. Although the
random primer had several mismatches with the downstream gyrB binding
site, a single nucleotide polymorphism 6 bp upstream from the 3' term
inus was found to distinguish O19 and non-O19 strains. PCR using 3'-mi
smatched primers based on this polymorphism was designed to differenti
ate O19 strains from non-O19 strains, When a total of 42 (18 O19 and 2
4 non-O19) strains from five different countries were examined, O19 st
rains were distinguishable from non-O19 strains in each case. This PCR
method should permit identification of O19 C. jejuni strains.